These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load. Generali D, Berruti A, Tampellini M, Dovio A, Tedoldi S, Bonardi S, Tucci M, Allevi G, Aguggini S, Milani M, Bottini A, Dogliotti L, Angeli A. Bone; 2007 Jan; 40(1):182-8. PubMed ID: 16935041 [Abstract] [Full Text] [Related]
27. Evidence that the IL-6/IL-6 soluble receptor cytokine system plays a role in the increased skeletal sensitivity to PTH in estrogen-deficient women. Masiukiewicz US, Mitnick M, Gulanski BI, Insogna KL. J Clin Endocrinol Metab; 2002 Jun; 87(6):2892-8. PubMed ID: 12050269 [Abstract] [Full Text] [Related]
28. Alendronate stimulation of nocturnal parathyroid hormone secretion: a mechanism to explain the continued improvement in bone mineral density accompanying alendronate therapy. Greenspan SL, Holland S, Maitland-Ramsey L, Poku M, Freeman A, Yuan W, Kher U, Gertz B. Proc Assoc Am Physicians; 1996 May; 108(3):230-8. PubMed ID: 8774056 [Abstract] [Full Text] [Related]
30. Acute effects in healthy women of oral calcium on the calcium-parathyroid axis and bone resorption as assessed by serum beta-CrossLaps. Zikán V, Haas T, Stepan JJ. Calcif Tissue Int; 2001 Jun; 68(6):352-7. PubMed ID: 11685423 [Abstract] [Full Text] [Related]
31. Calciotropic hormones and bone markers in the elderly. Gallagher JC, Kinyamu HK, Fowler SE, Dawson-Hughes B, Dalsky GP, Sherman SS. J Bone Miner Res; 1998 Mar; 13(3):475-82. PubMed ID: 9525348 [Abstract] [Full Text] [Related]
32. Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy. Vinholes J, Guo CY, Purohit OP, Eastell R, Coleman RE. J Clin Oncol; 1997 Jan; 15(1):131-8. PubMed ID: 8996134 [Abstract] [Full Text] [Related]
33. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover. Rosen HN, Dresner-Pollak R, Moses AC, Rosenblatt M, Zeind AJ, Clemens JD, Greenspan SL. Calcif Tissue Int; 1994 Jan; 54(1):26-9. PubMed ID: 8118749 [Abstract] [Full Text] [Related]
34. An acute intake of phosphate increases parathyroid hormone secretion and inhibits bone formation in young women. Kärkkäinen M, Lamberg-Allardt C. J Bone Miner Res; 1996 Dec; 11(12):1905-12. PubMed ID: 8970892 [Abstract] [Full Text] [Related]
37. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study. Szulc P, Munoz F, Marchand F, Chapuy MC, Delmas PD. Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693 [Abstract] [Full Text] [Related]
39. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944 [Abstract] [Full Text] [Related]
40. Influence of vitamin D on parathyroid function in the elderly. Quesada JM, Coopmans W, Ruiz B, Aljama P, Jans I, Bouillon R. J Clin Endocrinol Metab; 1992 Aug; 75(2):494-501. PubMed ID: 1639950 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]